Today, Vertex Pharmaceuticals Inc. released the initial Phase 3 clinical trial data for one of two next-generation, triple-combination modulators currently being tested.
Site Search
Showing 1 - 10 of 30 results
News
|
|
3 min read
A new drug intended to make it easier to clear mucus from the lungs of people with cystic fibrosis showed promising results in a Phase 2 clinical trial. The drug, called SPX-101, blocks the overactive sodium channels that line CF lung cells.
News
|
|
2 min read
News
|
|
1 min read
News
|
|
3 min read
News
|
|
2 min read
News
|
|
2 min read
This month, 15-year-old Molly Bonnell and her sister Emily, 13, who have cystic fibrosis, discovered how easy it is to make their voices heard in Congress -- without leaving their living room.
News
|
|
2 min read
News
|
|
2 min read
News
|
|
1 min read
News
|
|
2 min read